Burning Rock Biotech Limited
BNRNASDAQHealthcare● Active
$8.59
$-0.48(-5.29%)
Market Cap$9131522
P/E Ratio—
52W High$41.72
52W Low$2.95
Burning Rock Biotech Limited (BNR) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · BNR · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.54B | $0.52B | $0.54B | $0.56B | $0.51B |
| Cost of Revenue | $0.14B | $0.15B | $0.17B | $0.18B | $0.14B |
| Gross Profit | $0.40B | $0.36B | $0.36B | $0.38B | $0.36B |
| Gross Margin %(computed) | 74.67% | 70.26% | 67.59% | 67.47% | 71.70% |
| Operating Expenses | |||||
| R&D Expenses | $0.17B | $0.23B | $0.35B | $0.42B | $0.37B |
| G&A Expenses | $0.13B | $0.26B | $0.44B | $0.57B | $0.49B |
| Total Operating Expenses | $0.46B | $0.72B | $1.03B | $1.36B | $1.16B |
| Operating Income | ($0.05B) | ($0.36B) | ($0.67B) | ($0.98B) | ($0.80B) |
| Operating Margin %(computed) | -10.16% | -69.32% | -124.54% | -174.07% | -156.94% |
| Interest Income | $0.01B | $0.01B | $0.02B | $0.01B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | ($0.05B) | ($0.34B) | ($0.65B) | ($0.97B) | ($0.80B) |
| Income Tax Expense | $0.00B | $0.01B | $0.00B | $0.00B | $0.00B |
| Net Income | ($0.06B) | ($0.35B) | ($0.65B) | ($0.97B) | ($0.80B) |
| Net Margin %(computed) | -10.26% | -67.20% | -121.63% | -172.44% | -156.87% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-49.60 | $-33.67 | $-63.84 | $-93.47 | $-76.45 |
| Wtd Avg Shares | 0.00B | 0.01B | 0.01B | 0.01B | 0.01B |
| EBITDA | ($0.03B) | ($0.27B) | ($0.52B) | ($0.86B) | ($0.75B) |
| EBITDA Margin %(computed) | -5.93% | -52.39% | -96.37% | -152.03% | -146.99% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · CNY · B
Explore more Burning Rock Biotech Limited data
About Burning Rock Biotech Limited (BNR) Income Statement
Burning Rock Biotech Limited (BNR) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, BNR reported revenue of $0.54B, gross profit of $0.40B (gross margin 74.67%), and net income of ($0.06B) — a net profit margin of -10.26%.
Frequently asked questions
BNR · 4 questionsBurning Rock Biotech Limited (BNR) reported revenue of $0.54B for 2025, up 4.6% year-over-year.
BNR revenueBNR salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09